Andrew W. Lo


Andrew W. Lo


Andrew W. Lo is the Charles E. and Susan T. Harris Professor, a Professor of Finance, and the Director of the Laboratory for Financial Engineering at the MIT Sloan School of Management.

His current research spans five areas: evolutionary models of investor behavior and adaptive markets, systemic risk and financial regulation, quantitative models of financial markets, financial applications of machine-learning techniques and secure multi-party computation, and healthcare finance.  Recent projects include: deriving risk aversion, loss aversion, probability matching, and other behaviors as emergent properties of evolution in stochastic environments; constructing new measures of systemic risk and comparing them across time and systemic events; applying spectral analysis to investment strategies to decompose returns into fundamental frequencies; and developing new statistical tools for predicting clinical trial outcomes, incorporating patient preferences into the drug approval process, and accelerating biomedical innovation via novel financing structures.

Lo has published extensively in academic journals (see and his most recent book is Adaptive Markets: Financial Evolution at the Speed of Thought.  His awards include Batterymarch, Guggenheim, and Sloan Fellowships; the Paul A. Samuelson Award; the Eugene Fama Prize; the IAFE-SunGard Financial Engineer of the Year; the Global Association of Risk Professionals Risk Manager of the Year; the Harry M. Markowitz Award; the Managed Futures Pinnacle Achievement Award; one of TIME’s “100 most influential people in the world”; and awards for teaching excellence from both Wharton and MIT. His book Adaptive Markets has also received a number of awards, listed here. He is a Fellow of Academia Sinica; the American Academy of Arts and Sciences; the Econometric Society; and the Society of Financial Econometrics.

Lo is also a principal investigator at the MIT Computer Science and Artificial Intelligence Laboratory, an affiliated faculty member of the MIT Department of Electrical Engineering and Computer Science, an external faculty member of the Santa Fe Institute, and a research associate of the National Bureau of Economic Research. He is a member of the New York Federal Reserve Board’s Financial Advisory Roundtable, FINRA’s Economic Advisory Committee, the National Academy of Sciences Board on Mathematical Sciences and Their Applications, Beth Israel Deaconess Medical Center’s Board of Overseers, and the boards of Roivant Sciences and the Whitehead Institute for Biomedical Research.

Lo holds a BA in economics from Yale University and an AM and PhD in economics from Harvard University.


Pinnacle Achievement Award Given to Lo

GARP honors Lo as Risk Manager of the Year

Lo’s book wins PROSE Award

Markowitz Award given to Lo

Professor Andrew Lo elected to the Academy of Arts and Sciences


"Book Review."

Lo, Andrew W. Review of Reinventing Capitalism in the Age of Big Data, by Viktor Mayer Schönberger and thomas Ramge. Science, Forthcoming.

"Estimation of Clinical Trial Success Rates and Related Parameters."

Wong, Chi Heem, Kien Wei Siah, and Andrew W. Lo. Biostatistics. Forthcoming.

"Hedge Fund Holdings and Stock Market Efficiency."

Cao, Charles, Bing Liang, Andrew W. Lo, and Lubomir Petrasek. The Review of Asset Pricing Studies. Forthcoming.

"Is the FDA Too Conservative or Too Aggressive?: A Bayesian Decision Analysis of Clinical Trial Design."

Isakov, Leah, Andrew W. Lo, and Vahid Montazerhodjat. Journal of Econometrics. Forthcoming.

"Portfolio Theory."

Brennan, Thomas J., Andrew W. Lo and Tri-Dung Nguyen. In The Princeton Companion to Applied Mathematics, edited by N.J. Higham , Princeton, NJ: Princeton University Press, Forthcoming.

Survival of the Richest: Market Efficiency from an Evolutionary Perspective.

Lo, Andrew W. Princeton, NJ: Princeton University Press, Forthcoming.

Load More

Recent Insights

Ideas Made to Matter

Andrew Lo's adaptive market theory

‘It's really about taking chances on long shots.’

Read Article

New study by MIT Sloan researchers provides insights on the challenges of developing drugs for pediatric cancer—and offers a potential solution 

Study suggests that a collaborative investment approach between public and private institutions could greatly accelerate innovation.

Read Article
Load More